VOYA Investment Management
EWTX icon

VOYA Investment Management’s Edgewise Therapeutics EWTX Stock Holding History

VOYA Investment Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
94,671
+55,518
+142% +$1.91M ﹤0.01% 972
2026
Q1 		$1.23M Sell
39,153
-495
-1% -$14.3K ﹤0.01% 1394
2025
Q4 		$984K Buy
39,648
+27,231
+219% +$547K ﹤0.01% 1481
2025
Q3 		$201K Sell
12,417
-7,496
-38% -$106K ﹤0.01% 2186
2025
Q2 		$261K Sell
19,913
-260,822
-93% -$3.76M ﹤0.01% 2214
2025
Q1 		$6.18M Sell
280,735
-3,413
-1% -$89.5K 0.01% 886
2024
Q4 		$7.59M Sell
284,148
-23,694
-8% -$754K 0.01% 824
2024
Q3 		$8.22M Buy
307,842
+283,521
+1,166% +$5.64M 0.01% 831
2024
Q2 		$438K Buy
24,321
+6,025
+33% +$105K ﹤0.01% 2079
2024
Q1 		$334K Buy
18,296
+111
+0.6% +$1.76K ﹤0.01% 2200
2023
Q4 		$199K Hold
18,185
– – ﹤0.01% 2583
2023
Q3 		$104K Buy
18,185
+728
+4% +$4.95K ﹤0.01% 2717
2023
Q2 		$135K Buy
17,457
+3,849
+28% +$32.5K ﹤0.01% 2705
2023
Q1 		$90.8K Hold
13,608
– – ﹤0.01% 2717
2022
Q4 		$122K Buy
13,608
+1,727
+15% +$16.2K ﹤0.01% 2711
2022
Q3 		$117K Hold
11,881
– – ﹤0.01% 2742
2022
Q2 		$95K Sell
11,881
-2,919
-20% -$22.1K ﹤0.01% 2628
2022
Q1 		$144K Buy
14,800
+1,213
+9% +$15.6K ﹤0.01% 2441
2021
Q4 		$208K Buy
+13,587
New +$244K ﹤0.01% 2489

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VOYA Investment Management's EWTX Position: Q2 2026 in Review

VOYA Investment Management increased its Edgewise Therapeutics (EWTX) stake by 142% in Q2 2026, buying an estimated $1.91M and bringing the position to 94,671 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #972.

VOYA Investment Management first reported a position in EWTX in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.22M in Q3 2024. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • VOYA Investment Management held 94,671 shares of Edgewise Therapeutics worth $3.85M as of Q2 2026.
  • VOYA Investment Management bought 55,518 Edgewise Therapeutics shares in Q2 2026, an estimated $1.91M.
  • Edgewise Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #972 holding.
  • VOYA Investment Management first reported a position in Edgewise Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • VOYA Investment Management's Edgewise Therapeutics position peaked at $8.22M in Q3 2024.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.